Document
IPR2015-01554, No. 1024 Exhibit - David G Frame curriculum vitae (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1024 Exhibit - David G Frame curriculum vitae (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1010 Exhibit - US Patent No 5,202,333 (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1010 Exhibit - US Patent No 5,202,333 (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1029 Exhibit - Tr transcript Dr Candiotti direct (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1029 Exhibit - Tr transcript Dr Candiotti direct (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1003 Exhibit - US Patent No 7,947,725 (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1003 Exhibit - US Patent No 7,947,725 (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1044 Exhibit - Brown, The Effectiveness of a Single Intravenous Dose of Ondansetron (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1044 Exhibit - Brown, The Effectiveness of a Single Intravenous Dose of Ondansetron (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1048 Exhibit - Prosecution History of US Patent No 7,947,724 (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1048 Exhibit - Prosecution History of US Patent No 7,947,724 (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1031 Exhibit - FDA Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1031 Exhibit - FDA Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1023 Exhibit - Declaration of David G Frame, PharmD (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1023 Exhibit - Declaration of David G Frame, PharmD (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1007 Exhibit - Complaints for Patent Infringement 11 cv 03962 (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1007 Exhibit - Complaints for Patent Infringement 11 cv 03962 (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1013 Exhibit - Gralla, Recommendations for the Use of Antiemetics Evidence Based, Clinical Practice Guidelines (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1013 Exhibit - Gralla, Recommendations for the Use of Antiemetics Evidence Based, Clinical Practice Guidelines (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1034 Exhibit - October 3, 2001 Helsinn Press Release (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1034 Exhibit - October 3, 2001 Helsinn Press Release (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1032 Exhibit - Tr transcript Dr Candiotti direct (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1032 Exhibit - Tr transcript Dr Candiotti direct (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1050 Exhibit - Avis 2 Parental Drug Administration Routes, Precautions, Problems, Complications (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1050 Exhibit - Avis 2 Parental Drug Administration Routes, Precautions, Problems, Complications (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1054 Exhibit - Approved KYTRIL Label, Aug 16, 2002 (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1054 Exhibit - Approved KYTRIL Label, Aug 16, 2002 (P.T.A.B. Jul. 3, 2015)
+ More Snippets
Document
IPR2015-01554, No. 1047 Exhibit - Tr transcript Dr Candiotti cross examination (P.T.A.B. Jul. 3, 2015)
Cite Document
IPR2015-01554, No. 1047 Exhibit - Tr transcript Dr Candiotti cross examination (P.T.A.B. Jul. 3, 2015)
+ More Snippets